logo
logo

Precision Medicine Company Adyn Raises $2.5M Seed Funding For Personalized Birth Control

Precision Medicine Company Adyn Raises $2.5M Seed Funding For Personalized Birth Control

04/19/21, 1:03 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgseattle
Money raised
$2.5 million
Round Type
seed
adyn, a precision medicine company, announced today that it has closed a $2.5 million seed round of funding. The round was co-led by Lux Capital and M13 with participation from Civilization Ventures, Concrete Rose Capital, Y Combinator, Madrona Pioneer Fund, Ascend VC, and angel investors including Anne Wojcicki of 23andMe, Nish Bhat of Color Genomics, Qasar Younis of Applied Intuition, and Ashley Mayer of Glossier.

Company Info

Company
Adyn
Location
seattle, washington, united states
Additional Info
adyn is a precision medicine company that is making scientific discovery more inclusive so everyone can live their healthiest life. Founded in 2019, adyn provides medically actionable scientific insights and empowers individuals to proactively optimize their health—from birth control, to fertility, and beyond. For more information, follow adyn on Twitter, LinkedIn and Instagram. Please visit https://www.adyn.com.